A5087490339- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Valve Diseases and Treatments
- Aortic Disease and Treatment Approaches
- Coronary Artery Anomalies
- Congenital Heart Disease Studies
- Peripheral Artery Disease Management
- Cardiac Arrest and Resuscitation
- Acute Kidney Injury Research
- Liver Disease Diagnosis and Treatment
- Gastroesophageal reflux and treatments
- Liver Disease and Transplantation
- Cardiac Structural Anomalies and Repair
- Healthcare Policy and Management
- Cardiac Ischemia and Reperfusion
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Bacterial Identification and Susceptibility Testing
Ospedale Infermi di Rimini
2016-2025
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2018
Ospedale degli Infermi
2015
Ospedale degli Infermi
2015
Ospedale Maggiore
2010-2014
Azienda Ospedaliera S.Maria
2010-2014
University of Bologna
2010
Agenzia Sanitaria e Sociale Regionale
2010
GTx (United States)
2010
Arcispedale Sant'Anna
2010
The benefit of complete revascularization in older patients (≥75 years age) with myocardial infarction and multivessel disease remains unclear.In this multicenter, randomized trial, we assigned who were undergoing percutaneous coronary intervention (PCI) the culprit lesion to receive either physiology-guided nonculprit lesions or no further revascularization. Functionally significant identified by pressure wire angiography. primary outcome was a composite death, infarction, stroke, any at 1...
The role of quantitative flow ratio (QFR) in the treatment nonculprit vessels patients with myocardial infarction (MI) is a topic ongoing discussion.
Objectives To establish if the presence of chronic kidney disease (CKD) influences fractional flow reserve (FFR) value in patients with intermediate coronary stenosis. Background FFR‐guided revascularization reduces cardiac adverse events artery disease. CKD impairs microcirculation and increases cardiovascular risk. Whether may limit FFR accuracy is unknown. Methods We used data from a multicenter prospective registry enrolling 1.004 undergoing evaluation for assessed relationship between...
To examine the differences in cardiac outcomes for patients with ST-elevation myocardial infarction (STEMI) and multivessel disease (MVD) as a function of whether they underwent culprit-only primary percutaneous coronary intervention (PPCI) or PCI, either during PPCI staged procedure.MVD occurs about 40% presenting STEMI, it has been associated worse outcome compared to single-vessel disease. The most favorable PCI strategy dealing significant nonculprit lesions be established.A total 2061...
The revascularization strategy to pursue in older myocardial infarction (MI) patients with multivessel disease (MVD) is currently unknown. For this reason, while waiting for the results of dedicated trials, we sought compare a complete versus culprit-only MI by merging data from four registries.The inclusion criteria target population present study were (i) age ≥ 75 years; (ii) (STE or NSTE); (iii) MVD; (iv) successful treatment culprit lesion. Propensity scores (PS) derived using logistic...
We evaluated the effect of different dose hydration protocols, with normal saline or bicarbonate, on incidence contrast-induced acute kidney injury (CI-AKI) in patients ST-elevation myocardial infarction (STEMI) treated primary percutaneous coronary intervention (PPCI).We considered 592 STEMI PPCI 5 Italian centers. Patients were randomized to receive standard high-dose infusions sodium bicarbonate started immediately before contrast medium administration and continued for following 12 h.The...
Background: The service strategy (same-day transfer between spoke hospital and hub centre with catheterisation laboratory (cath-lab) facility to perform invasive procedures) has been suggested improve the management of patients non-STsegment elevation acute coronary syndrome (NSTEACS) admitted hospitals.We used data from a large prospective Italian registry describe application, performance outcome in daily clinical practice.Methods: This study was based on an observational, post-hoc...
To compare the long-term efficacy of cobalt-chromium bare-metal stents (CCSs) with that first-generation drug-eluting (DESs) in patients within a large real-world multicentre registry.The incidence major adverse cardiac events [death, acute myocardial infarction, and target-vessel revascularization (TVR)] angiographic stent thrombosis were assessed consecutive undergoing percutaneous coronary intervention CCS (n = 1103) or DES 5195) during 2-year follow-up. Propensity score-adjusted...
Abstract Coronary chronic total occlusion (CTO) produces an important clinical problem, often treated with medical therapy or coronary artery bypass grafting. Recent studies, both registries and randomized trials, demonstrated that percutaneous interventions (PCI), could provide a valid therapeutic option. Nonetheless, significant reduction in all-cause mortality, cardiac myocardial infarction, MACE, MACCE has not been the subgroups analysis of trials. These analyses suggest PCI for CTO...